HSDT vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HSDT exhibits critical financial distress, anchored by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company has suffered a catastrophic price collapse, falling from a 52-week high of $265.50 to $1.89, representing a nearly 100% loss in value over the past year. While revenue growth is nominally astronomical (3339.50%), it is offset by an unsustainable operating margin of -4429.90% and consistent negative earnings. Despite a high current ratio suggesting short-term liquidity, the overall trajectory is one of severe capital erosion.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
HSDT vs JPM: Head-to-Head Comparison
This page compares Solana Company (HSDT) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.